Recce Pharmaceuticals Announces Appointment of Global Infectious Disease Expert Professor Philip Sutton to H. Pylori Development ...
SYDNEY, Australia, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced the appointment of Professor Philip Sutton to their Clinical Advisory …